Drug

Ralinepag clinical trials

Also written APD811.

studies test it: 6
open now: 1
in phase 3: 3
first study started: 2014

How each study uses ralinepag is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ralinepag studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ralinepag: 6

Development codes

APD811: 5

Studies by the year they started

6 studies that test it; most in 2019 (2)

Studies that test ralinepag, by start year
Year	Studies
2014	1
2015	1
2019	2
2020	1
2021	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 2
Phase 3: 3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Pulmonary Arterial Hypertension: 3
Hypertension, Pulmonary: 2

Who runs them

Industry 6 · Other 0

United Therapeutics (5) · Everstar Medicines (Shanghai) Limited (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test ralinepag, phase 3 first.

Dec 2026A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPhase 3 · United Therapeutics

Studies

Open first, then newest update. How each study uses ralinepag is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 6

Codes

What other systems call ralinepag · ClinicalTrials.gg INT000730

MeSH (NLM) C000621069ralinepagOne source ClinicalTrials.gov
UNII (FDA) CQY12ZJN6ERALINEPAGConfirmed FDA, Wikidata
Wikidata Q27275655ralinepagConfirmed FDA, Wikidata
NCI Thesaurus C152148RalinepagOne source FDA
DrugBank DB12462One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	C000621069	ralinepag	One source ClinicalTrials.gov
UNII (FDA)	CQY12ZJN6E	RALINEPAG	Confirmed FDA, Wikidata
Wikidata	Q27275655	ralinepag	Confirmed FDA, Wikidata
NCI Thesaurus	C152148	Ralinepag	One source FDA
DrugBank	DB12462	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.